Histological regression of giant cell tumor of bone following RANK ligand inhibition

Martin F. Dietrich, Dominick C Cavuoti, Michael J Landay, Yull E Arriaga

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Lung metastases are a rare complication of giant cell tumors of bone. We herein describe an interesting case of histological regression and size reduction of lung metastases originating from a primary giant cell tumor of bone in response to the RANK ligand inhibitor denosumab.

Original languageEnglish (US)
JournalJournal of Investigative Medicine High Impact Case Reports
Volume2
Issue number4
DOIs
StatePublished - Jan 1 2014

Fingerprint

Giant Cell Tumor of Bone
RANK Ligand
Tumors
Bone
Ligands
Neoplasm Metastasis
regression
Lung
Denosumab

Keywords

  • Denosumab
  • Giant cell tumor
  • Lung metastases
  • RANK ligand

ASJC Scopus subject areas

  • Epidemiology
  • Safety, Risk, Reliability and Quality
  • Safety Research

Cite this

Histological regression of giant cell tumor of bone following RANK ligand inhibition. / Dietrich, Martin F.; Cavuoti, Dominick C; Landay, Michael J; Arriaga, Yull E.

In: Journal of Investigative Medicine High Impact Case Reports, Vol. 2, No. 4, 01.01.2014.

Research output: Contribution to journalArticle

@article{2b7cd47b487b49e390a0c6059344bbd3,
title = "Histological regression of giant cell tumor of bone following RANK ligand inhibition",
abstract = "Lung metastases are a rare complication of giant cell tumors of bone. We herein describe an interesting case of histological regression and size reduction of lung metastases originating from a primary giant cell tumor of bone in response to the RANK ligand inhibitor denosumab.",
keywords = "Denosumab, Giant cell tumor, Lung metastases, RANK ligand",
author = "Dietrich, {Martin F.} and Cavuoti, {Dominick C} and Landay, {Michael J} and Arriaga, {Yull E}",
year = "2014",
month = "1",
day = "1",
doi = "10.1177/2324709614560216",
language = "English (US)",
volume = "2",
journal = "Journal of Investigative Medicine High Impact Case Reports",
issn = "2324-7096",
publisher = "Sage Publications",
number = "4",

}

TY - JOUR

T1 - Histological regression of giant cell tumor of bone following RANK ligand inhibition

AU - Dietrich, Martin F.

AU - Cavuoti, Dominick C

AU - Landay, Michael J

AU - Arriaga, Yull E

PY - 2014/1/1

Y1 - 2014/1/1

N2 - Lung metastases are a rare complication of giant cell tumors of bone. We herein describe an interesting case of histological regression and size reduction of lung metastases originating from a primary giant cell tumor of bone in response to the RANK ligand inhibitor denosumab.

AB - Lung metastases are a rare complication of giant cell tumors of bone. We herein describe an interesting case of histological regression and size reduction of lung metastases originating from a primary giant cell tumor of bone in response to the RANK ligand inhibitor denosumab.

KW - Denosumab

KW - Giant cell tumor

KW - Lung metastases

KW - RANK ligand

UR - http://www.scopus.com/inward/record.url?scp=85012135732&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85012135732&partnerID=8YFLogxK

U2 - 10.1177/2324709614560216

DO - 10.1177/2324709614560216

M3 - Article

C2 - 26425630

AN - SCOPUS:85012135732

VL - 2

JO - Journal of Investigative Medicine High Impact Case Reports

JF - Journal of Investigative Medicine High Impact Case Reports

SN - 2324-7096

IS - 4

ER -